Effects of Progressive Muscle Relaxation Exercises During Pregnancy

Status Completed

Clinical Trial Summary

Participants were allocated into three groups; the control group, progressive muscle relaxation (PMR) group and relaxation music (RM) group. The PMR and RM programs were explained toall participants, and the first program was tested under the supervision of the researcher. PMR and RM group participants performed the program daily throughout 4 weeks. Severity of RLS with the International Restless Leg Syndrome Scale (IRLSS) and sleep quality with the Pittsburgh Sleep Quality Index (PSQI) were assessed at baseline, 2 and 4 weeks for all the groups.

Clinical Trial Description

A CD recorded by the Turkish Psychological Association was provided to explain relaxation techniques to PMR group participants. The CD contains relaxation exercises instructions and there is relaxing music in the background. This CD consists of two parts. The first part(11 minutes) gives short information about the content and how exercises should be done. It consists of information about deep relaxation. In the second part, there are 27 minutes of relaxation exercises accompanied by command with background music. PMR exercise consists of four stages: stretching-relaxation (1st stage -approximately 20 minutes), autogenic training - only relaxation (2nd stage approximately 10 minutes), deep breathing training-breathing relaxation (3rd stage approximately 3-4 minutes), rapid relaxation (4th stage--a few seconds). In the first stage, the participant was instructed to first stretch and then relax the specified muscle group (hand, forearm, upper arm, forehead, cheek, nose, chin, neck, chest, shoulder, waist, abdomen, stomach, hip, calf, foot) in sequence. The participant was asked to constantly compare the feeling of tension that shehas just experienced with the feeling of relaxation later. Another CD recorded by the Turkish Psychological Association was provided to RM group participants. It consists of 30 minutes relaxing music only.The participant was asked to just listen to music with without working in a private room. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05851001
Study type	Interventional
Source	Ege University
Contact
Status	Completed
Phase	N/A
Start date	April 1, 2016
Completion date	June 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04786314` - The Effect of Hot and Cold Water Application on Pregnant Women With Restless Leg Syndrome	N/A
Completed	`NCT01455012` - Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome	Phase 4
Terminated	`NCT01192503` - Safety and Efficacy of Rasagiline in Restless Legs Syndrome	Phase 2/Phase 3
Completed	`NCT00530530` - ASP8825 - Study in Patients With Restless Legs Syndrome	Phase 2
Completed	`NCT00721279` - Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome	N/A
Completed	`NCT00375284` - A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS	Phase 4
Completed	`NCT00942253` - Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)	Phase 2
Completed	`NCT00479531` - Sequential Compression Devices for Treatment of Restless Legs Syndrome	Phase 3
Recruiting	`NCT05581576` - Pitolisant in Refractory Restless Legs Syndrome	Phase 4
Active, not recruiting	`NCT03218969` - Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist	Phase 1/Phase 2
Recruiting	`NCT04144790` - Impact of Iron Supplementation Treatment on Brain Iron Concentrations
Completed	`NCT05787080` - Massage, Oxidative and Antioxidant Enzymes in Hemodialysis Patients With Restless Legs Syndrome(RLS)	N/A
Not yet recruiting	`NCT05529095` - Sublingual Apomorphine in Refractory Restless Legs Syndrome	Phase 4
Recruiting	`NCT05044520` - Clinical Features Associated With Restless Legs Syndrome.
Withdrawn	`NCT03849001` - Impact of Acute Leg Cycling at Various Intensities on RLS Severity in Persons With MS	N/A
Completed	`NCT03076541` - Cardiovascular Variability, Heart Rate Response, and Electromyogram Power Associated With Periodic Leg Movements.	N/A
Recruiting	`NCT04145674` - A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo	Phase 2
Completed	`NCT02532608` - Infra-slow Oscillations During Sleep	N/A
Completed	`NCT01528462` - Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
Completed	`NCT00748098` - Polysomnography Study of GSK1838262 Extended Release Tablets Versus Placebo in RLS and Associated Sleep Disturbance	Phase 3

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.